These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2881897)

  • 21. [Comparison of the effectiveness and tolerance of a new beta-2 stimulant (broxaterol) vs. salbutamol in patients with chronic obstructive bronchopneumopathy].
    Giosuè S; Guerrini P; Cafaggi R; D'Onofrio V; Perrone N; Scano M
    Clin Ter; 1987 Apr; 121(1):35-9. PubMed ID: 2885123
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
    Goldstein MF; Chervinsky P
    Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Broxaterol: therapeutic trials and safety profile.
    Ziment I
    Respiration; 1989; 55 Suppl 2():28-40. PubMed ID: 2572038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer.
    Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G
    Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics of broxaterol in asthmatic children].
    Flores D'Arcais A; Crippa L; De Biase D; Romagnoni G
    Minerva Pediatr; 1992 Sep; 44(9):421-5. PubMed ID: 1361960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchodilatory effect of inhaled zardaverine, a phosphodiesterase III and IV inhibitor, in patients with asthma.
    Brunnée T; Engelstätter R; Steinijans VW; Kunkel G
    Eur Respir J; 1992 Sep; 5(8):982-5. PubMed ID: 1426207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of intravenous broxaterol on respiratory drive and neuromuscular coupling in COPD patients.
    Gigliotti F; Gurrieri G; Duranti R; Gorini M; Scano G
    Eur Respir J; 1993 Mar; 6(3):371-7. PubMed ID: 8097170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Broxaterol: a new beta2-adrenoceptor agonist for the treatment of reversible airways disease. Proceedings of the satellite symposium. Budapest, September 8, 1988.
    Respiration; 1989; 55 Suppl 2():1-44. PubMed ID: 2572034
    [No Abstract]   [Full Text] [Related]  

  • 30. MMEF or FEV1 in estimating bronchial obstruction in asthmatic children.
    Dalén G; Kjellman B
    Allergy; 1983 Apr; 38(3):207-9. PubMed ID: 6846749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of two beta 2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis.
    Giustina A; Malerba M; Bresciani E; Desenzani P; Licini M; Zaltieri G; Grassi V
    J Endocrinol Invest; 1995 Dec; 18(11):847-52. PubMed ID: 8778156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Broxaterol: pharmacological profile of a unique structural feature.
    Della Bella D
    Respiration; 1989; 55 Suppl 2():10-4. PubMed ID: 2572035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of inhaled norepinephrine on the nitroglycerin-induced bronchodilatation in asthmatics.
    Rolla G; Bucca C; Brussino L
    Chest; 1995 Jan; 107(1):169-72. PubMed ID: 7813270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protective effect of transdermal broxaterol on exercise-induced bronchoconstriction.
    Robuschi M; Scuri M; Spagnotto S; Gambaro G; Lodola E; Pisati R; Bianco S
    Eur J Clin Pharmacol; 1995; 47(5):465-6. PubMed ID: 7720771
    [No Abstract]   [Full Text] [Related]  

  • 35. New drug evaluation using exercise-induced bronchospasm.
    Sprenkle AC; VanArsdel PP; Biermann CW
    Pediatrics; 1975 Nov; 56(5 pt-2 suppl):937-9. PubMed ID: 1187285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of FPL57787 in exercise-induced asthma.
    Thomson NC; Green AG; Kerr JW
    Clin Allergy; 1980 Jan; 10(1):43-6. PubMed ID: 7363445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged effect of inhaled glycopyrrolate in asthma.
    Walker FB; Kaiser DL; Kowal MB; Suratt PM
    Chest; 1987 Jan; 91(1):49-51. PubMed ID: 3792086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of misoprostol, a synthetic equivalent of prostaglandin E1, on bronchodilation in bronchial spasm].
    Marcisz C; Jonderko G; Gina R; Szkliniarz J
    Pol Tyg Lek; 1992 Aug 18-31; 47(34-35):733-4. PubMed ID: 1488359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ineffectiveness of intravenous beta 2-agonists on improving exercise tolerance in patients with reversible chronic airway obstruction.
    Malerba M; Boni E; Tantucci C; Filippi B; Romagnoni G; Grassi V
    Respiration; 1996; 63(1):8-16. PubMed ID: 8833987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of single doses of labetalol, metoprolol, and placebo on ventilatory function in patients with bronchial asthma: interaction with isoproterenol.
    Falliers CJ; Vincent ME; Medakovic M
    J Asthma; 1986; 23(5):251-60. PubMed ID: 3771472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.